Widely used:Recently Viewed
Clear All
Value Research Rating
Quality Score 
8/10
Growth
6/10
Valuation Score
2/10
Momentum Score
10/10
₹1,61,830 Cr
88.14
11.8
72.38
0
12.15 %
16.46 %
0.49 %
513.62
69
₹13,539.39 Cr
₹20,307.87 Cr
₹15,012.76 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Divi's Lab
| 56.16 | 3.29 | 19.61 | 60.51 | 8.62 | 27.50 | 21.66 |
|
BSE Sensex
| 13.19 | 3.79 | -0.71 | 18.73 | 12.32 | 14.89 | 11.09 |
|
BSE Healthcare
| 41.19 | 1.57 | 2.54 | 45.56 | 20.99 | 26.85 | 11.39 |
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
|
|---|---|---|---|---|---|---|---|
|
Divi's Lab
| 14.38 | -27.04 | 21.54 | 111.23 | 25.10 | 34.90 | 40.15 |
|
BSE Sensex
| 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 |
|
BSE Healthcare
| 36.97 | -12.10 | 20.87 | 61.45 | -3.55 | -5.89 | 0.49 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
--
--Min --Median --Max
--
--Min --Median --Max
--
Earnings Yield (%) = EBIT / Enterprise value
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 2,198.35 | 22,928.73 | 69.92 | 21.04 | |
| 1,372.00 | 25,920.91 | 52.03 | 19.45 | |
| 1,075.15 | 13,218.23 | 31.21 | 17.39 | |
| 17,846.35 | 22,914.05 | 81.93 | 19.73 |
Our rating system has guided millions of investors in the past 20 years.
₹1,61,829.65 Cr
₹8,614.00 Cr
₹1,836.00 Cr
₹3,602.00 Cr
₹0.00 Cr
51.89%
High
₹3,350.00 - 6,285.45
₹2.00
26,54,68,580
BSE: 532488, NSE: DIVISLAB
Hyderabad, Telangana
www.divislabs.com
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom... synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India. Read more
The total asset value of Divi's Laboratories Ltd stood at ₹ 15,467 Cr as on 30-Sep-24
The share price of Divi's Laboratories Ltd is ₹6,096.20 (NSE) and ₹6,096.00 (BSE) as of 05-Dec-2024 IST. Divi's Laboratories Ltd has given a return of 8.62% in the last 3 years.
Divi's Laboratories Ltd has a market capitalisation of ₹ 1,61,830 Cr as on 05-Dec-2024. As per Value Research classification, it is a Large Cap company.
The P/B ratio of Divi's Laboratories Ltd is 11.80 times as on 05-Dec-2024, a 177% premium to its peers’ median range of 4.26 times.
The P/E ratio of Divi's Laboratories Ltd is 88.14 times as on 05-Dec-2024, a 22% premium to its peers’ median range of 72.38 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Divi's Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Divi's Laboratories Ltd.
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.
The prominent promoters of Divi's Laboratories Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
NILIMA PRASAD DIVI |
20.34%
|
|
SATCHANDRA KIRAN DIVI |
20.34%
|
|
SWARNA LATHA DIVI |
5.27%
|
The chairman of the company is Ramesh BV Nimmagadda, and the managing director is Murali K Divi.
There is no promoter pledging in Divi's Laboratories Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
25,839
|
|
|
22,336
|
|
|
21,281
|
|
|
13,405
|
| Divi's Laboratories Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
13.55
|
|
Operating margin(%)
|
25.78
|
|
Net Margin(%)
|
20.9
|
|
Dividend yield(%)
|
0.49
|
Yes, TTM profit after tax of Divi's Laboratories Ltd was ₹1,836 Cr.
₹-160.30
